Patients with low tumor RRM1 expression assessed using either qRT‐PCR or IHC survived 3.94 months longer (95% CI, 2.15–5.73; P = 0.001) than those patients with high RRM1 expression. This evidence concerns the gene RRM1 and neoplasm.